Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | RAB9A | P51151 | 4/20 | 0.59 |
| ▸ | NPC1 | O15118 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Benzoate SCHEMBL21531031 | 0.92 | LMNA (0.63) | SMN1; SMN2RAB9ANPC1GAALMNA | |
| Ethyl Benzoate SCHEMBL25388294 | 0.90 | LMNA (0.70) | SMN1; SMN2RAB9ANPC1GAALMNA | |
| Ethyl Benzoate SCHEMBL55674 | 0.90 | LMNA (0.70) | SMN1; SMN2RAB9ANPC1GAALMNA | |
| Ethyl Benzoate SCHEMBL2762273 | 0.90 | LMNA (0.70) | SMN1; SMN2RAB9ANPC1GAALMNA | |
| Ethyl Benzoate SCHEMBL29554608 | 0.88 | LMNA (0.68) | SMN1; SMN2RAB9ANPC1GAALMNA | |
| Ethyl Benzoate SCHEMBL10340677 | 0.88 | LMNA (0.68) | SMN1; SMN2RAB9ANPC1GAALMNA | |
| Ethyl Benzoate SCHEMBL1404143 | 0.88 | LMNA (0.68) | SMN1; SMN2RAB9ANPC1GAALMNA | |
| Ethyl Benzoate SCHEMBL28871046 | 0.88 | LMNA (0.68) | SMN1; SMN2RAB9ANPC1GAALMNA | |
| Ethyl Benzoate SCHEMBL9345283 | 0.88 | LMNA (0.68) | SMN1; SMN2RAB9ANPC1GAALMNA | |
| Ethyl Benzoate SCHEMBL595705 | 0.88 | LMNA (0.68) | SMN1; SMN2RAB9ANPC1GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8026295-B2 | Curable acrylic mixture including a hindered amine light stabilizer having a 4-Amino-2,2,6,6-tetramethylpiperidin-1 oxyl moiety linked to an acrylic moiety so as to polymerize with the primary resin | DENTSPLY INTERNATIONAL, INC. (US) | 2011-09-27 | — | — | US | disclosed |
| US-20080103229-A1 | Dental composition with improved light stability | WALZ UWE | 2008-05-01 | — | — | US | disclosed |
| EP-1563821-B1 | Dental composition with light stability | DENTSPLY INT INC (US) | 2006-11-22 | — | — | EP | disclosed |
| EP-1255524-B1 | DENTAL COMPOSITION WITH LIGHT STABILITY | DENTSPLY INT INC (US) | 2005-12-21 | — | — | EP | disclosed |
| EP-1563821-A1 | Dental composition with light stability | DENTSPLY INTERNATIONAL, INC. (US) | 2005-08-17 | — | — | EP | disclosed |
| US-20040225029-A1 | Dental composition with improved light stability | WALZ UWE (US) | 2004-11-11 | — | — | US | disclosed |
| US-20030225182-A1 | Dental composition with improved light stability | DENTSPLY DETREY GMBH | 2003-12-04 | — | — | US | disclosed |
| EP-1255524-A1 | DENTAL COMPOSITION WITH LIGHT STABILITY | DENTSPLY INTERNATIONAL, INC. (US) | 2002-11-13 | — | — | EP | disclosed |
| US-20020002213-A1 | Dental composition with improved light stability | WALZ UWE (DE) | 2002-01-03 | — | — | US | disclosed |
| WO-2001060322-A1 | DENTAL COMPOSITION WITH LIGHT STABILITY | DENTSPLY INTERNATIONAL INC. (US) | 2001-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225182-A1 | Dental composition with improved light stability | RARA, MAP1LC3A, MAP1LC3C | SMN1; SMN2 1366/4885RAB9A 1444/4885NPC1 4466/4885 |
| US-20080103229-A1 | Dental composition with improved light stability | RARA, MAP1LC3A, MAP1LC3C | SMN1; SMN2 1366/4885RAB9A 1444/4885NPC1 4466/4885 |
| US-20020002213-A1 | Dental composition with improved light stability | MAP1LC3A, RARA, MAP1LC3C | SMN1; SMN2 1343/4885RAB9A 1392/4885NPC1 4480/4885 |
| US-20040225029-A1 | Dental composition with improved light stability | RARA, MAP1LC3A, MAP1LC3C | SMN1; SMN2 1366/4885RAB9A 1444/4885NPC1 4466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.